NCT00184613View on ClinicalTrials.gov

Comparison of Insulin Glargine Against Insulin Aspart Infused Under the Skin in Patients With Type 2 Diabetes

PHASE1CompletedINTERVENTIONAL

Enrollment

22

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

January 31, 2006

Conditions

DiabetesDiabetes Mellitus, Type 2Delivery Systems

Interventions

DEVICE

pump

DRUG

insulin glargine

DRUG

insulin aspart

Trial Locations (1)

8000

Novo Nordisk Investigational Site, Århus C

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY